Mia's Feed
Medical News & Research

U.S. Federal Government Commits to No-Bid Contract for Autism and Vaccine Research

U.S. Federal Government Commits to No-Bid Contract for Autism and Vaccine Research

Share this article

The U.S. Department of Health and Human Services plans to award a no-bid contract to research potential links between vaccines and autism, raising questions within the scientific community.

2 min read

In a recent development, the U.S. Department of Health and Human Services announced plans to award a no-bid contract to Rensselaer Polytechnic Institute (RPI) to investigate potential links between vaccinations and autism. This decision, communicated through a government procurement notice, highlights RPI's unique capacity to analyze data on children and mothers, which is the basis for the exclusive contractual agreement. The contract concerns ongoing research efforts, with RPI's biotech engineering professor Juergen Hahn poised to utilize artificial intelligence and machine learning techniques to search for patterns in blood samples of children diagnosed with autism. RPI officials have emphasized the anticipated publication of findings at the project's conclusion.

The move has sparked questions within the scientific community, especially given the long-standing consensus that vaccines are not linked to autism. Experts like Alycia Halladay from the Autism Science Foundation expressed skepticism, noting that RPI is not traditionally recognized for access to relevant data and that the funds might be better allocated to other research avenues, such as genetics or environmental factors.

U.S. Health Secretary Robert F. Kennedy Jr., known for his antivaccine stance before his appointment, previously announced a large-scale investigation into autism causes. Despite this, numerous rigorous studies over the past two decades have found no credible evidence supporting a connection between vaccines and autism. The controversy persists, partly fueled by political figures and misinformation.

The procurement notice also raises concerns about data access issues, with reports indicating that the CDC’s vaccine safety data has been difficult for researchers to access due to control by various organizations. Critics argue that this approach and expenditure divert resources from more established and evidence-based autism research, which emphasizes genetic and environmental factors. The scientific consensus remains that autism’s causes are complex, multifactorial, and not linked to vaccines.

Source: https://medicalxpress.com/news/2025-09-trump-administration-award-vaccines-autism.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

CDC Considers Banning Thimerosal in Vaccines Due to Safety Concerns

The CDC is considering banning thimerosal in vaccines due to safety concerns. Learn what you need to know about this preservative, its safety, and impact on vaccine availability.

Using Banking Data to Detect Early Signs of Cognitive Decline in Older Adults

New research shows that routine banking behaviors can reveal early signs of cognitive decline in older adults years before clinical diagnosis, enabling timely interventions.

Innovative Noninvasive Digital Model Accurately Detects Inflammatory Bowel Disease in Children

A groundbreaking noninvasive digital model demonstrates high accuracy in early detection of inflammatory bowel disease in children, offering a rapid and cost-effective diagnostic tool that complements traditional methods.